This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
tim.hodson Fri, 03/14/2025 - 16:12 SCAI Scientific Sessions 2025 will take place May 1 to 3, attheWalter E. Washington Convention Center in Washington, DC.
tim.hodson Thu, 01/30/2025 - 15:31 Jan. 29, 2025 Researchers atOchsner Health, led byHernan Bazan, MD, DFSVS, FACS, have developed a predictive model with a 93% accuracy rate in determining whether urgent carotid-intervention patients will regain functional independence. For information please visit Reference: Bazan HA et al.
tim.hodson Fri, 03/28/2025 - 15:23 Mar. vii Similarly, recent increases in Medicare reimbursement rates for CCTA are a positive step towards making this technology more accessible. a huge win: CMS significantly increases Medicare payments for cardiac CT. For more information on Revolution Vibe, please visit gehealthcare.com.
Stroke, Volume 56, Issue Suppl_1 , Page A63-A63, February 1, 2025. Introduction:Stroke prevalence is highest in adults ages>65 years, the majority of whom are Medicare beneficiaries. Fee-for-Service (FFS) Medicare incentivizes utilization by paying for each service. Improvements in functional outcomes were greater.
tim.hodson Thu, 03/27/2025 - 15:40 March 27, 2025 GE HealthCare is announcing theU.S.launch of Flyrcado(flurpiridaz F 18) injection at the 2025American College of Cardiology(ACC) AnnualScientific Session & Expo inChicago. Flyrcado is aunit dose positron emission tomography myocardial perfusion imaging (PET MPI) agent.
tim.hodson Mon, 03/31/2025 - 15:02 March 31, 2025 iRhythm Technologies, Inc. has announced results from two large real-world retrospective analyses presented at the American College of Cardiology (ACC) 2025 Scientific Sessions in Chicago. Long-term outcome of non-sustained ventricular tachycardia in structurally normal hearts.
Circulation: Cardiovascular Interventions, Volume 18, Issue 1 , Page e014592, January 1, 2025. We additionally compared end points across treatment arms using trial-adjudicated outcomes versus claims-based outcomes.RESULTS:Trial-adjudicated deaths were perfectly identified by claims.
tim.hodson Mon, 03/10/2025 - 11:17 At the Cardiovascular Research Technologies (CRT) 2025 conference in Washington, D.C., The analysis of data from SCAARon the Prevail coronary paclitaxel drug-coated balloon (DCB) will be presented as a late-breaking clinical trial at Cardiovascular Research Technologies (CRT) 2025 in Washington, D.C.
A study presented this week at The Society of Thoracic Surgeons 61st Annual Meeting explores findings in more than a million US Medicare beneficiaries who underwent CABG from 2001 to 2019. They noted that because their analysis was focused on the Medicare population, the cohort was limited to older patients.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP40-AWMP40, February 1, 2025. The highest visits among all disciplines were for PT and the payor covering the highest number of services was Medicare FFS at all time points: 30 days (mean 2.02, SD 3.04), 90 days (mean 4, SD 6.01), and at 1 year (mean 8.25, SD 12.8).
Stroke, Volume 56, Issue Suppl_1 , Page ATP205-ATP205, February 1, 2025. The primary outcome was non-traumatic intracranial hemorrhage, defined as a composite of intracerebral hemorrhage (ICH), subarachnoid hemorrhage (SAH), and subdural hemorrhage (SDH) using validatedICD-9-CMandICD-10-CMdiagnosis codes. andICD-10-CMcode G30.x.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP42-ATMP42, February 1, 2025. Results:Main outcome measures were the Medicare calculated self-care and mobility scores on admission and on discharge. 283 patients met at least one of their Medicare calculated discharge goals. minutes (PT), 830.3 minutes (OT), and 417.1
Stroke, Volume 56, Issue Suppl_1 , Page AWMP45-AWMP45, February 1, 2025. Home time is a valid measure of functional recovery in stroke patients that is often used in outcome studies. Patients admitted to IRF or SNF after hospital discharge were confirmed using claims data.
Stroke, Volume 56, Issue Suppl_1 , Page ATP328-ATP328, February 1, 2025. We longitudinally followed the patients by linking the registry data to the Center for Medicare&Medicaid Service (CMS) claims data. Objective:The role of statins in the management of intracerebral hemorrhage (ICH) remains controversial.
Stroke, Volume 56, Issue Suppl_1 , Page AWP140-AWP140, February 1, 2025. We evaluated the influence of early (30-day) post-acute care (PAC) pathways on 1-year HT.Methods:We analyzed a cohort of Medicare AIS patients at a 7-hospital stroke certified health system (2016 to 2020). One-year HT (i.e., female; 63.6% 0.76) (Figure 3).
Stroke, Volume 56, Issue Suppl_1 , Page AWP51-AWP51, February 1, 2025. The outcome was an incident diagnosis of dementia. The exposure and outcomes were identified using previously validatedICD-9andICD-10-CMdiagnosis codes.
Stroke, Volume 56, Issue Suppl_1 , Page AWP27-AWP27, February 1, 2025. Medicare) patients (1.82, 1.45 2.26) had higher odds of receiving surgical AVM treatment (Table 1). Further research is warranted to address these inequities and improve outcomes. NHW) patients (1.76, 1.20 2.58) and privately insured (vs.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP44-AWMP44, February 1, 2025. Conclusion:Cluster analyses can elucidate high-risk patient profiles and guide in identifying intervenable targets and prioritizing provision of appropriate care, including rehabilitation, to optimize long-term patient outcomes. vs. 28.5%) (Fig.
Stroke, Volume 56, Issue Suppl_1 , Page ATP120-ATP120, February 1, 2025. Introduction:AI-based Stroke Care Coordination Platforms (AI-SCCP) have been shown to improve patient transfer decisions and provide access to the highest quality standards of care for all patients.
Stroke, Volume 56, Issue Suppl_1 , Page ATMP37-ATMP37, February 1, 2025. This pattern was consistent across age groups and sex.Conclusions:Long-term survival after AIS has improved for White and Black Medicare FFS beneficiaries over time, while it remained largely unchanged for Hispanic and Other groups.
Stroke, Volume 56, Issue Suppl_1 , Page AWP235-AWP235, February 1, 2025. Disparities in outcomes of patients with ischemic stroke have been associated with insurance coverage. However, there are few studies investigating the impact of insurance status on outcomes in patients with intracerebral hemorrhage (ICH).Methods:We
Stroke, Volume 56, Issue Suppl_1 , Page AWP295-AWP295, February 1, 2025. In separate models, we estimated the odds ratio (OR) and 95% confidence intervals (CI) of three outcomes (inpatient mortality, 30-day mortality, and discharge home) using multilevel logistic models for clustered data, with data clustered at the county level.
Stroke, Volume 56, Issue Suppl_1 , Page AWP152-AWP152, February 1, 2025. Methods:This retrospective analysis utilized complete, de-identified inpatient Medicare data from January 1, 2016, to December 31, 2019. We included Medicare beneficiaries aged 65 years with incident AIS admissions in large metropolitan and non-urban settings.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP58-AWMP58, February 1, 2025. In spite of these advances, stroke outcomes continue to be reliant on factors only attributable to the patient. Patients using Medicare/Medicaid are more likely to have at least 1 SDOH compared to those with private insurance (2.19, 1.26-3.82,
tim.hodson Mon, 01/13/2025 - 16:47 Jan. 13, 2025 R3 Vascular Inc., We are eager to assess the impact of the MAGNITUDE scaffold on patient outcomes, which is now even closer to reality with the completion of these latest important milestones. Commenting on the announcements, Christopher M. Secemsky, M.D.,
tim.hodson Mon, 01/27/2025 - 09:47 Jan. tim.hodson Mon, 01/27/2025 - 09:47 Jan. This national coverage analysis was initiated by CMS in response to Medtronic's request to support Medicare beneficiary access to the SymplicitySpyral renal denervation (RDN) system, used in the Symplicity blood pressure procedure. 5 Bhatt, D.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content